Hadi Tabbaa

Hadi Tabbaa is a Managing Director at Foresite Capital, where he focuses on investor relations, capital raising, and business development. Foresite Capital invests across multi-stage opportunities (Seed through Growth/Expansion) in healthcare and life sciences, including biotechnology, therapeutics, genomics, diagnostics, life science tools, clinical trials, and applications of AI and big data. The firm raised a $900M fund in June 2024, and its portfolio includes companies such as Xaira, Latigo Bio, CG Oncology, and Juvenescence. Foresite Capital invests across the United States, including California (San Francisco Bay Area), New York City, and Massachusetts. Before Foresite, Hadi was Partner and Global Head of Investor Relations at B Capital Group and worked in marketing and investor relations at Coatue Management. Earlier, he held multiple roles at BlackRock (including Director, Institutional Client Coverage; Director, Corporate Development/Head of Cross-Border Transactions; and Associate, Financial Markets Advisory), and was an Associate in FIG Investment Banking at Barclays Capital. He also held roles at Capital One (Corporate Strategy) and McKinsey & Company, and completed earlier internships at Debevoise & Plimpton, Gunderson Dettmer, and the U.S. Securities and Exchange Commission. He studied at Stanford Law School and resides in Darien, Connecticut.